Quotient Sciences provides comprehensive bioanalytical services within a state-of-the-art facility. The experienced team of globally recognized experts can quickly develop, validate, and implement bioanalytical LC-MS, GC-MS, and ICP-MS assays for small- and large-molecule drugs, biomarkers, and elements in compliance with regulatory expectations. Our team have extensive project experience to support all stages of drug development, from early pre-clinical, FIH, and through to Phase II and III studies.
We produce bioanalytical LC-MS, GC-MS, and ICP-MS assays in compliance with regulatory standards. Three of our eight triple quadrupole (TQ) instruments are new, ultra-high sensitivity Waters Xevo® TQ-XS systems equipped with ultra-performance liquid chromatography (UPLC). In addition to this, we have a Sciex TripleTOF® 6600 that allows collection of high-resolution mass spectrometry data, and can be used to quantify an impressive range of molecules, from small molecules to proteins. When used in conjunction with the wide range of extraction technologies available to us, we can develop highly selective and sensitive assays.
Arcinova has officially become Quotient Sciences. You will now be automatically redirected to Quotient Sciences’ website.
If you are not automatically redirected, please click here www.quotientsciences.com